Enhancer, transcriptional, and cell fate plasticity precedes intestinal determination during endoderm development

  1. Ramesh A. Shivdasani1,2,6
  1. 1Department of Medical Oncology, Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA;
  2. 2Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02215, USA;
  3. 3Department of Genetics, Rutgers, the State University of New Jersey, Piscataway, New Jersey 08854, USA;
  4. 4Cancer Institute of New Jersey, Piscataway, New Jersey 08854, USA;
  5. 5Human Genetics Institute of New Jersey, Piscataway, New Jersey 08854, USA;
  6. 6Harvard Stem Cell Institute, Cambridge, Massachusetts 02139, USA
  1. Corresponding authors: ramesh_shivdasani{at}dfci.harvard.edu, verzi{at}dls.rutgers.edu
  1. 7 These authors contributed equally to this work.

Abstract

After acquiring competence for selected cell fates, embryonic primordia may remain plastic for variable periods before tissue identity is irrevocably determined (commitment). We investigated the chromatin basis for these developmental milestones in mouse endoderm, a tissue with recognizable rostro–caudal patterning and transcription factor (TF)-dependent interim plasticity. Foregut-specific enhancers are as accessible and active in early midgut as in foregut endoderm, and intestinal enhancers and identity are established only after ectopic cis-regulatory elements are decommissioned. Depletion of the intestinal TF CDX2 before this cis element transition stabilizes foregut enhancers, reinforces ectopic transcriptional programs, and hence imposes foregut identities on the midgut. Later in development, as the window of chromatin plasticity elapses, CDX2 depletion weakens intestinal, without strengthening foregut, enhancers. Thus, midgut endoderm is primed for heterologous cell fates, and TFs act on a background of shifting chromatin access to determine intestinal at the expense of foregut identity. Similar principles likely govern other fate commitments.

Keywords

Footnotes

  • Received July 18, 2018.
  • Accepted September 27, 2018.

This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml). After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.

| Table of Contents

Life Science Alliance